Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |